93 154
Pill imprint 93 154 has been identified as Ticlopidine hydrochloride 250 mg.
Ticlopidine is used in the treatment of cerebral thrombosis/embolism and belongs to the drug class platelet aggregation inhibitors. There is no proven risk in humans during pregnancy.
Ticlopidine 250 mg is not subject to the Controlled Substances Act.
See also related documents.
Ticlopidine hydrochloride Images
- Imprint:
-
93
154 - Strength:
- 250 mg
- Color:
- White
- Size:
- 15.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- butylated hydroxyanisole
corn starch
hypromellose
magnesium stearate
microcrystalline cellulose
polyethylene glycol
povidone
stearic acid
titanium dioxide
- Drug Class:
- Platelet aggregation inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
- 00093-0154
Advertisement
More Ticlopidine Hydrochloride resources
- Ticlopidine (Wolters Kluwer)
- ticlopidine (Cerner Multum)
- ticlopidine (Micromedex) - Includes Dosage Information
- Ticlopidine Hydrochloride (AHFS DI)
- Ticlopidine (FDA)
- Ticlopidine Hydrochloride (Wolters Kluwer)
Search Again
